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Background: In the clinical dentists and periodontal researchers’ community, there is an obvious demand for a
systems model capable of linking the clinical presentation of periodontitis to underlying molecular knowledge. A
computer-readable representation of processes on disease development will give periodontal researchers opportunities
to elucidate pathways and mechanisms of periodontitis. An ontology for periodontitis can be a model for integration
of large variety of factors relating to a complex disease such as chronic inflammation in different organs accompanied
by bone remodeling and immune system disorders, which has recently been referred to as osteoimmunology.
Methods: Terms characteristic of descriptions related to the onset and progression of periodontitis were manually
extracted from 194 review articles and PubMed abstracts by experts in periodontology. We specified all the relations
between the extracted terms and constructed them into an ontology for periodontitis. We also investigated matching
between classes of our ontology and that of Gene Ontology Biological Process.
Results: We developed an ontology for periodontitis called Periodontitis-Ontology (PeriO). The pathological
progression of periodontitis is caused by complex, multi-factor interrelationships. PeriO consists of all the required
concepts to represent the pathological progression and clinical treatment of periodontitis. The pathological processes
were formalized with reference to Basic Formal Ontology and Relation Ontology, which accounts for participants in the
processes realized by biological objects such as molecules and cells. We investigated the peculiarity of biological
processes observed in pathological progression and medical treatments for the disease in comparison with Gene
Ontology Biological Process (GO-BP) annotations. The results indicated that peculiarities of Perio existed in 1)
granularity and context dependency of both the conceptualizations, and 2) causality intrinsic to the pathological
processes. PeriO defines more specific concepts than GO-BP, and thus can be added as descendants of GO-BP
leaf nodes. PeriO defines causal relationships between the process concepts, which are not shown in GO-BP. The
difference can be explained by the goal of conceptualization: PeriO focuses on mechanisms of the pathogenic
progress, while GO-BP focuses on cataloguing all of the biological processes observed in experiments. The goal
of conceptualization in PeriO may reflect the domain knowledge where a consequence in the causal relationships
is a primary interest. We believe the peculiarities can be shared among other diseases when comparing processes
in disease against GO-BP.
Conclusions: This is the first open biomedical ontology of periodontitis capable of providing a foundation for an
ontology-based model of aspects of molecular biology and pathological processes related to periodontitis, as
well as its relations with systemic diseases. PeriO is available at http://bio-omix.tmd.ac.jp/periodontitis/.
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Biological high throughput analysis generates huge
amounts of biomedical data that can be used for investi-
gating disease mechanisms, and semantic technologies
are therefore expected to contribute to the effective use
of these data. Many biomedical ontologies such as the
Gene Ontology (GO), the Disease Ontology (DO), the
Ontology for General Medical Science (OGMS), the
Human Disease Ontology (DOID) and the Infectious
Disease Ontology (IDO) have been developed to provide
support for sophisticated biomedical information sys-
tems [1, 2]. These ontologies are providing a means for
the consistent representation of scientific data and the
domain entities made possible by these data [3].
Disease has been one of the major targets for ontol-
ogy development. The Unified Medical Language Sys-
tem (UMLS) [4] and the Medical Subject Headings
(MeSH) , a source vocabulary included in UMLS, [5]
are long established thesauri that explicate numerous
medical terms. For many decades, the World Health
Organization has provided International Classification
of Diseases (ICD) [6]. Terminologies and ontologies in
biology and medicine have also been reviewed by
Freitas et al. [7]. Meanwhile, large-scale genomic projects,
including the SNP consortium [8], the ENCODE pro-
ject [9], the NIH Knockout Mouse Project [10], the
Welcome Trust Case Control Consortium [11], and the
1000 Genome Project [12], have tried to catalogue
comprehensive relationships between genes and dis-
eases. These data collections require the development
of ontologies that integrate genes with clinical out-
comes [13–20]. Masci et al. created comprehensive
definitions of dendritic cells in order to distinguish
many derivatives of dendritic cells according to the pro-
gression of immune responses [20]. Mungall et al. investi-
gated ontological mapping of mutation phenotypes/
diseases across species [14]. Rubin et al. integrated
existing ontologies for neuronal connectivity in order to
explicate abnormalities of neuronal diseases systematically
[16]. Feltrin et al. and Lindeberg et al. expanded GO in
order to explicate muscle biology and plant pathology by
adding specifications of pathological disorders and muta-
tional phenotypes, respectively [17–19].
GO is an established ontology that consists of the fol-
lowing three sub-ontologies: Cellular Component (CC),
the parts of a cell or its extracellular environment; Mo-
lecular Function (MF), the elemental activities of a gene
product at the molecular level; and Biological Process
(BP), operations or sets of molecular events with a
defined beginning and end, pertinent to the functioning
of integrated living units such as cells, tissues, organs,
and organisms. While GO classifies internal processes
in any biological phenomenon with external links to
entries in the databases of genes by relationships of‘associated-to’, a specific relationship to GO [21,22],
disease-centered ontologies (DO, OGMS, DOID, and
IDO) only describe relationships between the processes
and external perturbations, including pathogens, drugs,
environmental factors, and medical devices, on the
diseases. As many bio-medical researchers strive to
understand diseases in the context of networks and
pathways in order to realize better and personalized
diagnoses and treatments in clinical medicine, molecu-
lar interpretations of both the external causes and the
internal processes of disease have demanded biological
high throughput analyses in order to elucidate molecu-
lar mechanisms of pathogenesis and progression. GO is
currently used in biological high throughput analyses
by detecting overrepresented GO terms in case groups
relative to a control group [23–25]; however, we do not
consider that GO covers all the required internal pro-
cesses of disease, because internal disease processes
may be different from the processes observed under
healthy conditions. The difference can be observed not
only in the classification of the internal processes, but
also in the relationships between the internal processes
and their participants and activators and/or suppressors to
these processes [26]. Some ontologies have attempted to
include annotations of genes associated with internal
processes specific to the diseases such as an ontology for
diabetes [2, 27]; however, those ontologies cover only a
small number of existent diseases.
Periodontitis is a multifactorial disease causing in-
flammation in periodontal tissue. The pathogenesis of
periodontitis includes numerous biological entities such
as oral microorganisms and immune and genetic fac-
tors, physical effects such as dental occlusion, drugs,
and chemicals, environmental factors, and interactions
with systemic diseases such as diabetes and cardiovas-
cular diseases.
As systematic mechanisms underlying periodontitis
are complex, it remains difficult to elucidate relation-
ships and interactions between the multiple risk factors
through studies on individual molecules only. Analyses
based on pathways and networks are required in order
to elucidate relationships and interactions from ‘omics
data’, such as genomics, transcriptomics, proteomics,
and metabolomics observed in molecular pathways that
are involved in the pathogenesis and progression of
periodontitis [28]. Actually, gene expression data from
periodontal tissue has allowed the partial elucidation of
such molecular pathways [29]. However, previous ana-
lyses of detecting disease-specific processes have not
been so successful. This may be due to the complexity
of periodontitis, as well as to the way results from
omics analyses have been semantically interpreted. In
omics analysis, GO is generally used in annotations of the
data; however, few processes specific to periodontitis are
Table 1 The full texts and abstracts used in this study
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GO by using a periodontitis-specific extension.
Kornman proposed a systems model to link the clin-
ical presentation of periodontitis to underlying molecu-
lar knowledge and thus better clarify the pathogenesis
of periodontal diseases [30].
In the past decade, molecular details have been elucidated
in periodontitis comparison with other osteoimmunology-
based diseases such as rheumatoid arthritis [31].
Osteoimmunology is an interdisciplinary science inves-
tigating the interplay between the skeletal and the
immune systems. The main contributors to osteoim-
munology are bone effector cells such as osteoclasts or
osteoblasts, and immune cells, particularly lymphocytes
and monocytes [32]. Osteoimmunology has now become
one of the most prominent research areas in clinical biol-
ogy, and periodontitis is considered to be a good model
for the study of the common mechanisms in osteoimmu-
nology and the progression of target diseases. Several
studies relating periodontitis to osteoimmunology have re-
cently been reported [33, 34].
In this paper, we report on Periodontitis-Ontology
(PeriO), an ontology we developed for periodontitis.
This ontology covers and formally describes a variety of
entities that stand in relation to periodontitis. PeriO
describes relationships between molecular mechanisms
of inner processes in periodontitis and pathogenesis
and progression in a clinical view of the disease, as well
as relationships between molecular influences of drugs
and environmental molecules and clinical medications
and treatments.
Content integrated into our PeriO includes the follow-
ing: 1) functional classification of bacterial molecules in
periodontal lesions; 2) interactions between periodontitis
and other systemic diseases; 3) environmental chemicals
affecting periodontitis; and 4) processes of medical treat-
ments for and the molecular pathogenesis of periodontitis.
Methods
PeriO is based on our previous development of ontology,
which specified the bone resorption response induced by
periodontitis [35]. Bone resorption is one part of a larger
process in the onset and progression of periodontitis; the
entire process is composed of many biological processes
and clinical actions. We systematized the entire process in
this study as PeriO.
Extraction of terms relating to periodontitis
We retrieved review articles for periodontitis by from
the PubMed using keywords of ‘periodontitis, biology,
human and review’ on April 30, 2014. In order to col-
lect mentions of molecules and cells participating in
processes we formalized in PeriO, we investigated
PubMed abstracts reporting on the individual processconcepts. References to concepts were manually extracted
from review articles and abstracts by experts in periodon-
tology (authors of this manuscript) when the terms were
related to its onset and progression.
Ontology Construction
We developed PeriO using OBO-Edit version 2.3-beta5.
OBO-Edit is an open source, platform-independent
ontology editor developed and maintained by the Gene
Ontology Consortium. OBO-Edit is a tool for domain
experts to browse, search, and edit ontologies. OBO-Edit
continues to undergo active development in response to
the needs of its users [36, 37].
Comparison of PeriO classes with GO-BP
We investigated matching between classes of PeriO and
that of GO-BP. Every class of PeriO was manually
examined against classes of GO-BP as to whether an
equivalent class was found in GO-BP. AMIGO (http://
amigo.geneontology.org/amigo) was employed to search
GO-BP.
Results
Extraction of terms that were characteristic in
descriptions of periodontitis
We identified 194 review articles from PubMed on the
development, progression, and treatment of periodon-
titis. From the collected articles, we excluded those
reporting on apical periodontitis because it is a distinct
disease from general periodontitis in terms of molecular
pathology.
A total of 101 articles were available as full texts, 79
articles were available as abstracts only, and 14 articles
were unavailable (Table 1). All 14 unavailable articles
were written in languages other than English, with the
only useful information being the titles.
The 194 articles were published in a total of 50 jour-
nals, the five most frequent of which were Journal of
Periodontology (21 articles), Periodontology 2000 (16
articles), Journal of Clinical Periodontology (16 articles),
Journal of Dental Research (12 articles) and Annals of
periodontology (8 articles) (Additional file 1).
In addition, we collected abstracts related to the medical
treatment and molecular pathogenesis of periodontitis.
We found 22 abstracts on ‘medical treatment for oral bio-
film’, 229 on ‘medical treatment for inflammation’, 58 on
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‘laboratory test for periodontitis’ in the process of
medical treatment for periodontitis, 117 on ‘formation
of oral biofilm’, 477 on ‘inflammation in gingiva’, 137 on
‘invasion of bacteria’, and 225 on ‘pathological bone re-
sorption’ in the process of molecular pathogenesis of
periodontitis.
We manually extracted 1,347 characteristic terms of
periodontitis from the review articles and abstracts re-
trieved from PubMed. We systematized the extracted
terms and developed an ontology called ‘PeriO’. The
distribution of classes according to top categorization
in PeriO is shown in Table 2.Structure of PeriO
Top categories in is-a hierarchy
We categorized concepts denoted by the extracted terms
on molecular pathology and periodontal processes into a
‘is-a’ hierarchy. Our categorization refers to Basic Formal
Ontology (BFO) [38] and OBO Relation Ontology (OBO-
RO) [39]. BFO is a top-level ontology that serves as a
domain-neutral framework for the development of lower
level ontologies in many specialist disciplines, above all in
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Total 1,347distinctions between: (a) universal and particular; (b) con-
tinuant and occurrent; (c) dependent and independent;
and (d) formal and material [38]. OBO-RO provides
consistent and unambiguous formal definitions of rela-
tions used in biomedical ontologies. It focuses on defini-
tions of general-purpose relations that can be employed,
in principle, in all biological ontologies, including ‘is_a’,
‘part_of ’, ‘located_in’, ‘contained_in’, ‘adjacent_to’, ‘transfor-
mation_of ’, ‘derives_from’, ‘preceded_by’, ‘has_participant’,
and ‘has_agent’ [39].
Top categories of PeriO were inherited from BFO
and OGMS [40] (Figure 1). This ontology starts with
‘entity’, which is divided into ‘occurrent’ and ‘continu-
ant’. ‘Occurrent’ subsumes ‘process’, which subsumes
‘molecular pathogenesis of periodontitis’ and ‘medical
treatment for periodontitis’. ‘Continuant’ subsumes ‘in-
dependent entity’ and ‘specifically dependent entity’; the
former subsumes ‘cell’, ‘cell part’, ‘extended organism’, ‘living
organism’, ‘medical material’, ‘molecule’, ‘molecule aggregate’,
and ‘organism aggregate’,. The latter subsumes ‘disposition’,
which subsumes ‘disease’. Edges in Fig. 1 indicate ‘is_a’ or
‘has_part’ relations. All arguments in PeriO are embraced
in the domain of the molecular pathology of periodontitis.Properties characterize classes
In PeriO, the classes are linked by relations such as ‘is_a’
and ‘has_part’. We follow the definition in the OBO-RO
[39]: ‘is_a’ (OBO-RO:0000001) and ‘has_part’ (OBO-
RO:0000003). The classes are characterized by 1) PubMed
IDs of reference papers reporting on characterization of
the term; 2) synonymous terms from reference papers;
and 3) IDs of corresponding entries in existing biomedical
ontologies. Our hierarchical conceptual tree consists of
both ‘is_a’ and ‘has_part’ relationships and allows multiple
parenthood in both taxonomic and partonomic hierarch-
ies. We tried to make PeriO directly reflect background
knowledge of experts on periodontology as much as pos-
sible, so as to make the ontology familiar to the domain
experts and facilitate the application of the ontology in
periodontitis research. As the success of GO shows, ontol-
ogies are useful in omics research with both taxonomic
and partonomic hierarchies.
The interoperability of existing biomedical ontologies
is an important property of the characterization of the
concepts. The terms are characterized by correspond-
ing ontologies as follows: 1) GO for the class ‘process’;
2) Chemical Entities of Biological Interest Ontology
(ChEBI) [41] for the class ‘molecule’ and ‘medical ma-
terial’; 3) Cell Ontology (CL) [42] for the class ‘cell’; 4)
Foundational Model of Anatomy Ontology (FMA) [43]
for the class ‘organism part’; and 5) Experimental Fac-
tor Ontology (EFO) [44] for the class ‘anatomy’, ‘disease’
and ‘chemical compounds’.
Fig. 1 A hierarchy of upper categories in our ontology for molecular pathology in periodontitis. This figure shows upper categories from the first
to the seventh level of PeriO. It shows all the classes in the first, second, third, fourth, and fifth levels, while only representative classes are shown
in the sixth and seventh levels. Edges in solid lines indicate ‘is_a’ relations. Edges in broken lines indicate ‘has_part’ relations. Classes in red were
inherited from BFO. Classes in blue were inherited from OGMS
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In PeriO, we regard ‘process’ as the most important
class for describing molecular mechanisms of disease
development in periodontitis (Fig. 2). The ‘process’
class was modeled referring to BFO [38] and RO [39],
and specified by additional relations such as ‘prece-
ded_by’, ‘located_in’, ‘has_participant’, ‘has_active_agent’
and ‘has_suppressive_agent’.
1. ‘preceded_by’ (OBO-RO:0000017): is a process
preceded by the process by causal relation in a
cascade of molecular processes. Both the processes
should belong to ‘process’ class.
2. ‘located_in’ (OBO-RO:0000008): is a place where the
process occurs. The place should belong to
‘extended organism’ or ‘cell’ class.
3. ‘has_participant’ (OBO-RO:0000019): is an object
that participates in the process. The object should
belong to ‘cell’ or ‘living organism’ class.
4. ‘has_active_agent’ (subclass of OBO-RO:0000021): is
an object that participates in the process and causally
activates the process. The object should belong to
‘molecule’ class including ‘human molecule’ and
‘bacterial molecule’ class.5. ‘has_suppressive_agent’ (subclass of OBO-
RO:0000021): is an object that participates in the
process and causally suppresses the process. The
object should belong to ‘molecule’ class including
‘human molecule’ and ‘bacterial molecule’ class.
We followed the relations defined in OBO-RO. As
‘has_active_agent’ and ‘has_suppressive_agent’ were derived
relations from OBO-RO, we defined them as follows:
A. ‘has_active_agent’: is a subclass of ‘has_agent’
(OBO-RO:0000021) representing a relation whose
consequence is activation of a process in which the
agent participates.
B. ‘has_suppresive_agent’: is a subclass of ‘has_agent’
(OBO-RO:0000021) representing a relation whose
consequence is suppression of a process in which
the agent participates.
Fig. 3 shows how these relations specify a ‘process’,
taking ‘invasion of bacteria to soft tissue’ as an example.
As shown in GO-BP, relations between processes and
biological entities play significant roles in the computa-
tional analysis of omics data. We specified the relations
Fig. 2 Process characterizing periodontitis. ‘Process’ subsumes two counter concepts of ‘molecular pathogenesis of periodontitis’, a process of
development of periodontitis, and ‘medical treatment for periodontitis’, a process of recovery from periodontitis. Individual processes are divided
into sub-processes by ‘has_part’ relationships. Please note ‘preceded by’ relations (causal relationships) characterize the sub-processes of ‘molecular
pathogenesis of periodontitis’, which indicates essential features following a specified event in time causing a disease state as a consequence
in periodontitis
Fig. 3 Characterization of a process concept by relations to concepts under ‘continuant’ class. We take ‘invasion of bacteria to soft tissue’ as an
example. The process is characterized by 10 kinds of concepts subsumed by ‘continuant’ class with relations such as ‘located_in’, ‘has_participant’,
‘has_active_agent’, ‘has_suppressive_agent’. These relations illustrate that the process of ‘invasion of bacteria to soft tissue’ occurs in gingiva and
periodontal ligaments containing B-lymphocytes, phagocytes, and microorganisms, actively regulated by bacterial outer membrane proteins,
endopeptidase, and histamine, as well as systemic disease of diabetes, and suppressed by drugs for periodontitis. Every relation is annotated by a
reference paper reporting on a reason of the relation
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suppressive_agent’; and ‘has_participant’. While ‘has_ac-
tive_agent’ and ‘has_suppressive_agent’ relations are
accounted by the class ‘molecule’ including ‘human mol-
ecule’ and ‘bacterial molecule’, ‘has_participant’ relations
are accounted by the class ‘cell’ and ‘living organism’
including ‘bacterium’. That reflects background know-
ledge of domain experts on periodontology:
1) The domain experts have major interests in
molecules that can regulate (activate or suppress)
the ‘process’ because they explore a molecule that
can change the process of malignant into benign
consequence. The molecules and their regulation
(activation or suppression) provide clues for
development of drugs for periodontitis.
2) The experts regard processes in periodontitis as
subsequent interactions among cells and bacteria
mediated by active or suppressive interventions of
biological molecules. In the view of BFO/RO,
participants are played by cells and living organisms,
which discriminates PeriO from GO-BP, in which
participants are played by molecules (gene products).Representation of process in PeriO, in comparison with GO
Representation of inner biological processes in periodontitis,
in comparison with GO
PeriO mainly targets the collection and classification of
biological processes in the pathogenesis and progression of
periodontitis. As GO-BP is frequently used for annotation
of omics data, formalized knowledge of inner processes of
biological phenomena provides us with a guide to mine
useful information from massive data such as genome-
wide gene expression profiles. The popularity comes from
the fact that biologists consider biological processes as
manifestations of causal relationships between biological
molecules that result in observable biological phenomena,Fig. 4 Comparison between PeriO and Biological Process ontology in GO (GO
Process in GO (GO-BP) with ‘is_a’ or ’has_part’ relationships. This indicates that
as contexts of periodontitis than GO-BP. The classes in PeriO are characte
the significance of secession among processes and of consequence of theven though the details of their causal relationships have
not been clearly elucidated.
GO-BP includes almost all of the processes known in
the research domain of biology; however, the ontology
does not include the class ‘periodontitis’. Therefore, we
investigated whether the classes of GO-BP match those
we collected for specification of periodontitis. We investi-
gated differences between GO-BP and PeriO. Additional
file 2 and Additional file 3 show the results of mapping
between the classes of both ontologies. We found that
most of the classes for processes in PeriO could be
mapped to the classes of GO-BP, in a way of 1) equiva-
lent class, 2) class with ‘is_a’ relationship, or 3) class
with ‘has_part’ relationship. For example, ‘multinucleation
of osteoclast’ (in PeriO) was linked to ‘multinuclear osteo-
clast differentiation’ (GO:0072674) by an ‘equivalent’ rela-
tionship, ‘production of M-CSF’ (in PeriO) was linked to
‘production of molecular mediator involved in inflamma-
tory response’ (GO:0002532) by an ‘is_a’ relationship, and
‘survival of osteoclast’ (in PeriO) was linked to ‘osteoclast
development’ (GO: 0036035) by a ‘has_part’ relationship.
In the mapping results, we should pay attention to
the fact that we needed ‘is_a’ or ‘has_part’ relations for
the mappings. This fact indicated that PeriO included
more specific concepts than GO-BP. This specificity is
illustrated in Fig. 4. PeriO describes the biological
processes observed in certain cells and genes specific to
periodontitis, i.e., the cells migrated into the periodon-
tal lesions and the genes activated in the periodontal
lesions. Sometimes such specific processes are named
very differently in GO-BP. This is particularly the case
in subclasses of ‘bone remodeling’ and ‘negative regulation
of bone remodeling’, both of which are most character-
istic processes of periodontal pathology. PeriO specifies
‘degradation of bone matrix in gingival crevicular fluid’,
which is connected to the BP class ‘bone remodeling’ in
BP via the existentially qualified relation (‘has_part’).
PeriO specifies ‘loss of balance between bone resorption-BP). The classes of PeriO can be mapped to the classes of Biological
PeriO defines more specific concepts specific to tissues and cells as well
rized by causal (‘preceded by’) relationships in series, which represents
e successive processes resulting in a disease-state
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exceeds osteoblastic bone formation’, both of which are
connected to the BP class ‘negative regulation of bone re-
modeling’ via the existentially qualified relation (‘has_-
part’). These classes of PeriO identify minute details
observed specifically in periodontal lesions and peri-
odontal progression. These concepts can compose a
subset of classes added as descendants of GO-BP leaf
nodes, which can enhance GO-BP by a periodontitis-
specific extension. We believe that such a subset of
disease specific concepts will be useful when analyzing
data with more disease specificity and obtaining out-
comes with more clinical validity.
We also found a certain difference between PeriO andGO-
BP in the structure of relationships between the concepts
for processes. While GO-BP defines ‘is_a’ and/or ‘part_of ’
relationships among the process concepts, PeriO primarily
defines causal relationships (‘preceded_by’) between the
process concepts (Fig. 4). The structure based on causality
is familiar to the domain experts including dentists who
consider periodontitis as a conclusion of a series of pro-
cesses that occur in periodontal lesions. Therefore, the
domain experts regard the causal relationships in patho-
genesis and progression of periodontitis as most important.
In the OBO-Editor (OBO-Edit), the causal relationships
cannot be directly represented in tree style in its ontology
viewer, so we provisionally numbered the classes in se-
quence in order to represent ‘precedent_by’ relationships
among the concepts for processes (e.g., ‘1 formation of oral
biofilm’ and ‘2 inflammation in gingiva’), which is regarded
as more important for reasoning than ‘is_a’ in the peri-
odontal research domain.
In conclusion, we found peculiarities of PeriO existed
in 1) granularity and context dependency of both the
conceptualizations, and 2) causality intrinsic to the patho-
logical processes: 1) PeriO defines more specific concepts
that can be inserted under the leaf concepts of GO-BP,
and 2) GO-BP uses ‘is_a’ and/or ‘part_of ’ relationships,
while PeriO primarily consists of causal relationships in
case of formalization of process concepts. We believe this
can be common to other diseases when comparing pro-
cesses in disease against GO-BP.Representation of medical treatment for periodontitis, in
comparison with GO
Our PeriO includes concepts on ‘medical treatment for
periodontitis’ in alignment with ‘molecular pathogen-
esis of periodontitis’. We considered that PeriO should
specify biological processes not only for development
of, but also of recovery from disease.
Sub-categories of ‘medical treatment for periodontitis’
were counterbalanced with the sub-categories of ‘mo-
lecular pathogenesis of periodontitis’, as exemplified incomparison with the top three categories of both classes
(Fig. 2):
molecular pathogenesis of periodontitis
has_part formation of oral biofilm
has_part inflammation in gingiva
has_part pathological bone resorption
medical treatment for periodontitis
has_part negative regulation of formation of oral biofilm
has_part negative regulation of inflammation in gingiva
has_part negative regulation of pathological bone
resorption.
The mirror image indicated that medical treatments
were taken to individual processes in the development
into periodontitis, which could be reasonable considering
that medical treatments using modern technology target
the biological processes observed in the progress of the
disease.
In order to investigate the symmetrical relationships
between ‘medical treatment for periodontitis’ and ‘molecu-
lar pathogenesis of periodontitis’, we again mapped the
terms to GO-BP. As Additional file 3 shows, most of all
the classes under ‘medical treatment for periodontitis’
were mapped to the classes in GO-BP, with the excep-
tion of ‘laboratory tests for periodontitis’. When map-
ping to GO-BP, both the corresponding classes of
‘medical treatment for periodontitis’ and ‘molecular
pathogenesis of periodontitis’ linked to the same or
closely related GO-BP classes. For example (Fig. 5),
‘bone remodeling’ (GO:0046849) was referred not only
by ‘pathogenic shift of bone remodeling’ and ‘destruc-
tion of alveolar bone’, but also by ‘keep balance between
bone resorption and bone formation’ and ‘maintenance
of structural integrity of bone’. The same was true for
‘osteoblast development’ (GO:0002076).
Fig. 5 illustrates relationships between classes of ‘med-
ical treatment for periodontitis’, ‘molecular pathogenesis
of periodontitis’, and GO-BP. The classes in GO-BP
represented something neutral without premising clin-
ical contexts. When premising clinical contexts, the
GO-BP classes should be specialized in features of the
development into or recovery from a certain disease state
such as periodontitis. GO-BP defines the biological foun-
dation of a certain biological process observed in a ubiqui-
tous context, while PeriO defines roles of the biological
process in contexts of either the development into or the
recovery from periodontitis.
Specific classes to periodontitis
PeriO includes specific classes not included in MeSH,
ICD, GO, or KEGG. ‘Bacterial molecule’ (‘is_a’ ‘molecule’)
Fig. 5 Relationships in Process between PeriO and GO. This figure illustrates relationships between classes of ‘medical treatment for periodontitis’,
‘molecular pathogenesis of periodontitis’, and GO-BP. ‘Bone remodeling’ (GO:0046849) is referred not only by ‘pathogenic shift of bone remodeling’
and ‘destruction of alveolar bone’, but also by ‘keep balance between bone resorption and bone formation’ and ‘maintenance of structural integrity
of bone’
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are the specific classes. These represent features specific
to periodontitis.
‘Bacterial molecule’ represents a protein produced by
a bacterium. Entities that belong to ‘bacterial molecule’
are classified from a viewpoint of their influences upon
the generation and progression of periodontitis. ‘Bacterial
molecule’ is grouped into ‘exotoxin’ and ‘endotoxin’ ac-
cording to toxic properties against human cells. After the
first grouping, the molecules are categorized according to
their functions in periodontal pathogenesis.
‘Regenerative dental material’ represents material used
in clinical treatments for alveolar bone and gingival re-
generation. ‘Regenerative dental material’ is related to
‘periodontal regeneration therapy’ by ‘has_agent’.
Labeling for identical names of different functionality or
species
The ‘chemical and drug’ class subsumes several meta-
bolic products used as drugs. Examples are ‘estrogen’
and ‘histamine’. In order to distinguish these drugs from
biological metabolic products, PeriO uses the name of a
drug combined with the name of its functionality:
‘estrogen [human]’ is_a ‘human molecule’
‘estrogen [drug]’ is_a ‘drug’
The ‘bacterial molecule’ class subsumes homologous
genes to humans. Similar naming is employed in order to
discriminate the genes. For example, ‘collagenase’ is a pro-
tein produced by both humans and bacteria. In this case,
PeriO uses a name of a gene combined with the name of
its species:‘collagenase [human]’ is_a ‘human molecule’
‘collagenase [bacteria]’ is_a ‘bacterial molecule’.
Ontological specification for recognition of clinical
dentists and periodontal researchers
PeriO uses several networks among molecules based on
basic textbooks in order to explicate knowledge implicit
for clinical dentists and periodontal researchers (Fig. 6).
This pathway indicates interactions between bacteria
and periodontal tissue and their induced cellular causal
networks that result in periodontitis.
Fig. 7 shows the interactions between the cells that in-
duce pathological processes such as ‘osteoclastogenesis
and alveolar bone resorption’ and ‘bone loss’ (‘is_a’ ‘mo-
lecular pathogenesis of periodontitis’ ‘is_a’ ‘pathological
bone resorption’ ‘is_a’ ‘process’) and connective tissue
destruction responses result in ‘periodontitis’ (‘is_a’ ‘peri-
odontal disease’ ‘is_a’ ‘disorder of teeth and/or supporting
structures’ ‘is_a’ ‘disorder of digestive system’ ‘is_a’ ‘dis-
ease’) as a consequence. This causal flow is influenced by
‘bisphosphonate’ (‘is_a’ ‘anti-bone resorption drug’ ‘is_a’
‘drug for periodontitis’ ‘is_a’ ‘chemical and drug’) and by
‘diabetes’ (‘is_a’ ‘metabolic disease’ ‘is_a’ ‘disease’). PeriO
specifies all the entities of this pathway; therefore, PeriO
provides implicit agreements.
Discussion
Limitation of PeriO and future research
Although we investigated 101 review articles of full texts
and 1,391 abstracts in building our ontology, we do not
consider the current PeriO to be complete. Additional
knowledge should be collected from more original articles;
however, due to the rapid accumulation of publications in
Fig. 6 Clinical interpretation of process ‘invasion bacteria to soft tissue’ in the molecular pathogenesis of periodontitis. Clinical dentists and periodontal
researchers assigned pathological processes in PeriO to clinical pathways based on specific knowledge
Fig. 7 Ontological specification for recognition of clinical dentists and periodontal researchers. This figure shows a simplified pathway for the onset
and progression of periodontitis, which many clinical dentists and periodontal researchers agree on. All of the biochemical and clinical entities are
specified in PeriO. Entities in this figure are shown in colours according to class
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Fig. 8 Relation between periodontitis and systemic disease. Relations between periodontitis and systemic diseases are divided into four categories
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spreading over the clinical, medical, biological, chemical,
and bacterial disciplines, manual collection of new know-
ledge is resource intensive and thereby quite difficult. We
consider this ontology as a core resource of knowledge for
future development of computational tools that enable us
to automatically extract classes from the literature. A
natural language processing tool is under development for
the suggestion of new ontology content on the basis of
PeriO.Application to other complex diseases
There is an obvious need for systematic integration of
information in multiple levels of substances, cells, or-
gans, and clinical outcomes in periodontology [41, 45].
Currently, many web sites maintain highly elaborated
structured knowledge for diseases like Alzheimer’s
disease [46], Crohn's Disease [47], and asthma [48], as
well as many other diseases. Specific ontologies must
be developed for specific diseases because every disease
includes knowledge specific to that disease. PeriO, with its
upper categorization and relations between the higher
classes, can be reused in ontological development for
other diseases.Relationship between periodontitis and systemic diseases
Although periodontal lesions are located in the oral
cavity, they may induce other systemic diseases such as
cardiovascular diseases and diabetes. Actually, progres-
sion of periodontitis interdepends on various diseases
with mediation mainly by osteoimmune responses.
Medical treatments for periodontitis can significantly
affect the progression of many systemic diseases. We
collected mentions of systemic diseases related to peri-
odontitis from the articles listed in Additional file 1
and classified them into the following seven categories
based on ICD10: ‘disorder by body site’; ‘disorder offetus or newborn’; ‘disorder of immune function’; ‘infec-
tious disease’; ‘metabolic disease’; ‘neoplastic disease’; and
‘syndrome’. We investigated relationships between peri-
odontitis and the systemic diseases and found the follow-
ing four patterns (Fig. 8):
1. ‘comorbidity induced by periodontitis’, which relates
such diseases as ‘coronary heart artheriosclerosis’
and ‘low birth weight infant’ with ‘periodontitis’.
2. ‘increased susceptibility to periodontitis by the
disease’, which relates such diseases as ‘type I
diabetes’ and ‘Papillon-Lefevre syndrome’ with
‘periodontitis’.
3. ‘deteriorated oral care by mental and physical
disability’, which relates such diseases as ‘Alzheimer’s
disease’ with ‘periodontitis’.
4. ‘shared biological mechanisms in pathological
processes’, which relates such diseases as ‘rheumatism’
and ‘collagen-induced arthritis’ with ‘periodontitis’.
Although this is an early result of specification for inter-
dependency among diseases, these relations are expected
to be helpful in the comprehensive collection and analysis
of the interdependence between different diseases in
larger-scale studies in the future.
We plan on logically formalizing these relations on the
basis of RO in our next study.Conclusions
In PeriO, we explicated all types of entities contributing
to the development, progression, and treatment of peri-
odontitis. PeriO explicates relations between processes
and other entities with reference to BFO and RO,
which accounts for participants in the processes real-
ized by biological objects such as molecules and cells.
Comparing the ‘process’ class with GO-BP, we found
the following differences in conceptualization of both
Suzuki et al. Journal of Biomedical Semantics  (2015) 6:30 Page 12 of 13the ontologies:1) PeriO defines more specific concepts
than GO-BP; these concepts can be added as descen-
dants of GO-BP leaf nodes; and 2) GO-BP uses ‘is_a’
and/or ‘part_of ’ relationships, while PeriO primarily
consists of causal relationships; this indicates the in-
trinsic causality in conceptualization of the processes in
periodontitis, reflecting the domain knowledge where a
consequence in the causal relationships is a primal
interest by the domain experts (periodontal doctors
and researchers). We believe this can be common to
other diseases when comparing processes in diseases
with GO-BP.
PeriO can be a model for ontological integration of
knowledge for other multifactorial diseases like chronic
inflammation in different organs and disorders of immune
systems. Formalization of processes brings opportunities
for clinical dentists and periodontal researchers to eluci-
date pathways and mechanisms of the pathogenesis and
progression of periodontitis and clinical treatment. As
PeriO was founded on extracted knowledge, more know-
ledge should be collected from original articles using text
mining techniques and employing PeriO as a reference
ontology.
PeriO is available at http://bio-omix.tmd.ac.jp/peri-
odontitis/ and Additional file 4 in OBO format.
Additional files
Additional file 1: This file contains references of the reviews used
in this study.
Additional file 2: This Table contains all the mapping results of the
classes in processes of molecular pathogenesis of periodontitis
between PeriO and GO-BP.
Additional file 3: This table contains all the mapping results of the
classes in processes of medical treatment for periodontitis between
PeriO and GO-BP.
Additional file 4: PeriO in OBO format version 2.3-beta 5.
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